Allspring Global Investments
OPRX icon

Allspring Global Investments’s OptimizeRx OPRX Stock Holding History

Allspring Global Investments’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,615
Closed -$12.6K – 2584
2023
Q3 		$12.6K Buy
1,615
+300
+23% +$3.27K ﹤0.01% 2588
2023
Q2 		$18.8K Buy
+1,315
New +$18.7K ﹤0.01% 2470
2023
Q1 		– Sell
-800
Closed -$13.4K – 2893
2022
Q4 		$13.4K Sell
800
-18
-2% -$311 ﹤0.01% 2660
2022
Q3 		$12K Sell
818
-57,374
-99% -$1.13M ﹤0.01% 2707
2022
Q2 		$1.59M Sell
58,192
-5,605
-9% -$166K ﹤0.01% 1303
2022
Q1 		$2.4M Buy
63,797
+10,814
+20% +$479K ﹤0.01% 1408
2021
Q4 		$3.29M Buy
+52,983
New +$4.01M ﹤0.01% 1323

Other funds holding OPRX

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
GIPM
G2 Investment Partners Management New York $549M AUM 179.59% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SM
Samjo Management New York $293M AUM 57.03% 1-Year Est. Return

Allspring Global Investments's OPRX Position: Q4 2023 in Review

Allspring Global Investments sold out of OptimizeRx (OPRX) in Q4 2023, closing a stake of 1,615 shares — an estimated $12.6K sold.

Allspring Global Investments first reported a position in OPRX in Q4 2021 and held it in 7 quarters. The position peaked at $3.29M in Q4 2021. 98 funds tracked by Wall St. Rank hold OPRX as of Q4 2023.

  • Allspring Global Investments reported no remaining OptimizeRx position as of Q4 2023 after selling out during the quarter.
  • Allspring Global Investments sold 1,615 OptimizeRx shares in Q4 2023, an estimated $12.6K.
  • Allspring Global Investments first reported a position in OptimizeRx in Q4 2021 and held it in 7 quarters.
  • Allspring Global Investments's OptimizeRx position peaked at $3.29M in Q4 2021.
  • 98 funds tracked by Wall St. Rank held OptimizeRx as of Q4 2023.

Based on Allspring Global Investments's 13F filing for Q4 2023, filed 25 Jan 2024.